Etiology and pathogenesis of uterine leiomyomas: A review

Comparative Pathobiology Group, Laboratory of Experimental Pathology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
Environmental Health Perspectives (Impact Factor: 7.03). 07/2003; 111(8):1037-54. DOI: 10.1289/ehp.5787
Source: PubMed

ABSTRACT Uterine leiomyomas, or fibroids, represent a major public health problem. It is believed that these tumors develop in the majority of American women and become symptomatic in one-third of these women. They are the most frequent indication for hysterectomy in the United States. Although the initiator or initiators of fibroids are unknown, several predisposing factors have been identified, including age (late reproductive years), African-American ethnicity, nulliparity, and obesity. Nonrandom cytogenetic abnormalities have been found in about 40% of tumors examined. Estrogen and progesterone are recognized as promoters of tumor growth, and the potential role of environmental estrogens has only recently been explored. Growth factors with mitogenic activity, such as transforming growth factor- (subscript)3(/subscript), basic fibroblast growth factor, epidermal growth factor, and insulin-like growth factor-I, are elevated in fibroids and may be the effectors of estrogen and progesterone promotion. These data offer clues to the etiology and pathogenesis of this common condition, which we have analyzed and summarized in this review.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: It is common to utilise herbal extracts such as Silybum marianum and Rosmarinus officinalis in naturopathic practice to support hepatic function and improve oestrogen clearance, but what pharmacodynamic evidence is there to support this hypothesis? This article explores the potential use of these two traditional hepatic herbs for the potential treatment of uterine fibroids via and their action on specific CYP450 enzymes. Uterine fibroids are benign smooth muscle overgrowths which occur in various locations in the myometrium and develop from an unknown cause. There is however a wide diversity of known promoters involved in the pathogenesis including steroid hormones, such as oestrogen. Excessive oestrogen synthesis from aromatase P450 can lead to an overexpression of alpha (ER-í µí»¼) and beta (ER-í µí»½) oestrogen receptors, which through binding activity, causes a cascade of growth factors contributing to fibroid development. Considering this increased oestrogen activity has been implicated in stimulating uterine tissue, a novel approach to treating uterine fibroids is by inducing CYP1A1 and inhibiting CYP3A4 to improve the ratio between 2:16 hydroxy catechol oestrogens. Silybum marianum has shown potential in inhibiting CYP3A4 activity in vitro, but evidence from two small clinical trials did not support this. Rosmarinus officinalis shows promise by improving 2:16 hydroxy catechol oestrogen ratio equilibrium in vivo by inducing CYP1A1 and inhibiting CYP3A4 activity. Rosmarinus officinalis may have a role in altering these pathways and therefore may help to reduce the excessive uterotropic action of oestrogen and its metabolites by shifting the metabolism of oestrogen to a less proliferative pathway, but further clinical research is required.
  • [Show abstract] [Hide abstract]
    ABSTRACT: It has been suggested that the development of uterine leiomyomas is positively influenced by an immune system in a chronically inflammatory state and that a lower level of regulating T cell (Treg cells) would play a central role. Since it has been suggested that the W620 variant of protein tyrosine phosphatase non-receptor type 22 (PTPN22) decreases the number of Treg cells, we investigated a possible relationship between PTPN22 polymorphism and uterine leiomyomas.
    European Journal of Obstetrics & Gynecology and Reproductive Biology 12/2014; 185. DOI:10.1016/j.ejogrb.2014.11.043 · 1.63 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Does tumor necrosis factor-α (TNF-α) differentially regulate matrix metalloproteinase-2 (MMP-2) expression in leiomyomas compared with normal myometrium?
    Human Reproduction 11/2014; DOI:10.1093/humrep/deu300 · 4.59 Impact Factor

Full-text (2 Sources)

Available from
May 21, 2014